Similar articles

• World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries.

  Mendis S, Lindholm LH, Mancia G, Whitworth J, Alderman M, Lim S, Heagerty T. Mendis S, et al. J Hypertens. 2007 Aug;25(8):1578-82. doi: 10.1097/HJH.0b013e3282861fd3. J Hypertens. 2007. PMID: 17620952
• Stroke and cardiovascular diseases: the need for a global approach for prevention and drug development.

  Hilbrich L, Truelsen T, Yusuf S. Hilbrich L, et al. Int J Stroke. 2007 May;2(2):104-8. doi: 10.1111/j.1747-4949.2007.00118.x. Int J Stroke. 2007. PMID: 18705961 Review.
• The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.

  Bennett DE, Bertagnolio S, Sutherland D, Gilks CF. Bennett DE, et al. Antivir Ther. 2008;13 Suppl 2:1-13. Antivir Ther. 2008. PMID: 18578063
• Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.

  Greving JP, Buskens E, Koffijberg H, Algra A. Greving JP, et al. Circulation. 2008 Jun 3;117(22):2875-83. doi: 10.1161/CIRCULATIONAHA.107.735340. Epub 2008 May 27. Circulation. 2008. PMID: 18506010
• Critical care in low-income countries.

  Baker T. Baker T. Trop Med Int Health. 2009 Feb;14(2):143-8. doi: 10.1111/j.1365-3156.2008.02202.x. Epub 2009 Jan 21. Trop Med Int Health. 2009. PMID: 19207174 Review.